AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
MUTATIONS IN THE P53 GENE, BOTH WITHIN AND OUTSIDE THE ZINC-BINDING DOMAINS, ARE ASSOCIATED WITH INCREASED APOPTOSIS AND MITOSIS IN INVASIVE BREAST CARCINOMAS
Authors: VANSLOOTEN HJ VANVIJVER MJ BORRESEN AL EYFJORD E VALGARODOTTIR R SCHERNECK S NESLAND JM DEVILEE P CORNELISSE CJ VANDIERENDONCK JH
Citation: Hj. Vanslooten et al., MUTATIONS IN THE P53 GENE, BOTH WITHIN AND OUTSIDE THE ZINC-BINDING DOMAINS, ARE ASSOCIATED WITH INCREASED APOPTOSIS AND MITOSIS IN INVASIVE BREAST CARCINOMAS, European journal of cancer, 34, 1998, pp. 537-537
LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP
Authors: DEVILEE P HERMANS J EYFJORD J BORRESEN AL LIDEREAU R SOBOL H BORG A CLETONJANSEN AM OLAH E COHEN B SCHERNECK S HAMANN U PETERLIN B CALIGO M BIGNON YL MAUGARD C ANDERSEN TI ODEGAND AEM BIECHE I BIRNBAUM D CORNELISSE CJ SZTAN M STEEL MR SEITZ S LOGAR N GOLOUH R GHIMENTI C BRUELLE S JOALLAND MP
Citation: P. Devilee et al., LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP, Genes, chromosomes & cancer, 18(3), 1997, pp. 193-199
RELATIONSHIP BETWEEN ABNORMAL P53 PROTEIN AND FAILURE TO EXPRESS P21 PROTEIN IN HUMAN BREAST CARCINOMAS
Authors: BUKHOLM IK NESLAND JM KARESEN R JACOBSEN U BORRESEN AL
Citation: Ik. Bukholm et al., RELATIONSHIP BETWEEN ABNORMAL P53 PROTEIN AND FAILURE TO EXPRESS P21 PROTEIN IN HUMAN BREAST CARCINOMAS, Journal of pathology, 181(2), 1997, pp. 140-145
ANGIOGENESIS DOES NOT PREDICT CLINICAL-RESPONSE TO DOXORUBICIN MONOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER
Authors: PAULSEN T AAS T BORRESEN AL VARHAUG JE LONNING PE AKSLEN LA
Citation: T. Paulsen et al., ANGIOGENESIS DOES NOT PREDICT CLINICAL-RESPONSE TO DOXORUBICIN MONOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, International journal of cancer, 74(1), 1997, pp. 138-140
A SEGREGATION ANALYSIS OF TESTICULAR CANCER BASED ON NORWEGIAN AND SWEDISH FAMILIES
Authors: HEIMDAL K OLSSON H TRETLI S FOSSA SD BORRESEN AL BISHOP DT
Citation: K. Heimdal et al., A SEGREGATION ANALYSIS OF TESTICULAR CANCER BASED ON NORWEGIAN AND SWEDISH FAMILIES, British Journal of Cancer, 75(7), 1997, pp. 1084-1087
SPECIFIC P53 MUTATIONS ARE ASSOCIATED WITH DE-NOVO RESISTANCE TO DOXORUBICIN IN BREAST-CANCER PATIENTS
Authors: AAS T BORRESEN AL GEISLER S SMITHSORENSEN B JOHNSEN H VARHAUG JE AKSLEN LA LONNING PE
Citation: T. Aas et al., SPECIFIC P53 MUTATIONS ARE ASSOCIATED WITH DE-NOVO RESISTANCE TO DOXORUBICIN IN BREAST-CANCER PATIENTS, Nature medicine, 2(7), 1996, pp. 811-814
MUTATIONS AND POLYMORPHISMS IN THE FAMILIAL EARLY-ONSET BREAST-CANCER(BRCA1) GENE
Authors: COUCH FJ WEBER BL BORRESEN AL BRODY L CASEY G DEVILEE P FITZGERALD M FRIEND S GAYTHER S GOLDGAR D MURPHY P SZABO C WEBER B WISEMAN R ANDERSON T DUROCHER F GANGULY A KING MC LENOIR G NAROD S OLOPADE O PLUMMER S PONDER B SEROVA O SIMARD J STRATTON M WARREN B
Citation: Fj. Couch et al., MUTATIONS AND POLYMORPHISMS IN THE FAMILIAL EARLY-ONSET BREAST-CANCER(BRCA1) GENE, Human mutation, 8(1), 1996, pp. 8-18
ALTERATIONS OF P53 AND EXPRESSION OF WAF1 P21 IN HUMAN THYROID-TUMORS/
Authors: ZEDENIUS J LARSSON C WALLIN G BACKDAHL M ASPENBLAD U HOOG A BORRESEN AL AUER G
Citation: J. Zedenius et al., ALTERATIONS OF P53 AND EXPRESSION OF WAF1 P21 IN HUMAN THYROID-TUMORS/, Thyroid, 6(1), 1996, pp. 1-9
TP53 ALTERATIONS IN ATYPICAL DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA IN-SITU OF THE BREAST
Authors: CHITEMERERE M ANDERSEN TI HOLM R KARLSEN F BORRESEN AL NESLAND JM
Citation: M. Chitemerere et al., TP53 ALTERATIONS IN ATYPICAL DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA IN-SITU OF THE BREAST, Breast cancer research and treatment, 41(2), 1996, pp. 103-109
INVOLVEMENT OF THE PRH P16/CDK4/CYCLIN D1 PATHWAY IN THE TUMORIGENESIS OF SPORADIC MALIGNANT MELANOMAS/
Authors: MAELANDSMO GM FLORENES VA HOVIG E OYJORD T ENGEBRAATEN O HOLM R BORRESEN AL FODSTAD O
Citation: Gm. Maelandsmo et al., INVOLVEMENT OF THE PRH P16/CDK4/CYCLIN D1 PATHWAY IN THE TUMORIGENESIS OF SPORADIC MALIGNANT MELANOMAS/, British Journal of Cancer, 73(8), 1996, pp. 909-916
FAMILIAL TESTICULAR CANCER IN NORWAY AND SOUTHERN SWEDEN
Authors: HEIMDAL K OLSSON H TRETLI S FLODGREN P BORRESEN AL FOSSA SD
Citation: K. Heimdal et al., FAMILIAL TESTICULAR CANCER IN NORWAY AND SOUTHERN SWEDEN, British Journal of Cancer, 73(7), 1996, pp. 964-969
RISK OF CANCER IN RELATIVES OF TESTICULAR CANCER-PATIENTS
Authors: HEIMDAL K OLSSON H TRETLI S FLODGREN P BORRESEN AL FOSSA SD
Citation: K. Heimdal et al., RISK OF CANCER IN RELATIVES OF TESTICULAR CANCER-PATIENTS, British Journal of Cancer, 73(7), 1996, pp. 970-973
A COMMON BRCA1 MUTATION IN NORWEGIAN BREAST AND OVARIAN-CANCER FAMILIES
Authors: ANDERSON TI BORRESEN AL MOLLER P
Citation: Ti. Anderson et al., A COMMON BRCA1 MUTATION IN NORWEGIAN BREAST AND OVARIAN-CANCER FAMILIES, American journal of human genetics, 59(2), 1996, pp. 486-487
BREAST-CANCER INFORMATION ON THE WEB
Authors: FRIEND S BORRESEN AL BRODY L CASEY G DEVILEE P GAYTHER S GOLDGAR D MURPHY P WEBER BI WISEMAN R
Citation: S. Friend et al., BREAST-CANCER INFORMATION ON THE WEB, Nature genetics, 11(3), 1995, pp. 238-239
ASSOCIATION STUDIES OF ESTROGEN-RECEPTOR POLYMORPHISMS IN A NORWEGIANTESTICULAR CANCER POPULATION
Authors: HEIMDAL K ANDERSEN TI SKREDE M FOSSA SD BERG K BORRESEN AL
Citation: K. Heimdal et al., ASSOCIATION STUDIES OF ESTROGEN-RECEPTOR POLYMORPHISMS IN A NORWEGIANTESTICULAR CANCER POPULATION, Cancer epidemiology, biomarkers & prevention, 4(2), 1995, pp. 123-126
ALTERATIONS OF THE TP53 GENE AS A POTENTIAL PROGNOSTIC MARKER IN BREAST CARCINOMAS - ADVANTAGES OF USING CONSTANT DENATURANT GEL-ELECTROPHORESIS IN MUTATION DETECTION
Authors: ANDERSEN TI BORRESEN AL
Citation: Ti. Andersen et Al. Borresen, ALTERATIONS OF THE TP53 GENE AS A POTENTIAL PROGNOSTIC MARKER IN BREAST CARCINOMAS - ADVANTAGES OF USING CONSTANT DENATURANT GEL-ELECTROPHORESIS IN MUTATION DETECTION, Diagnostic molecular pathology, 4(3), 1995, pp. 203-211
DELETION OF IP LOCI AND MICROSATELLITE INSTABILITY IN COLORECTAL POLYPS
Authors: LOTHE RA ANDERSEN SN HOFSTAD B MELING GI PELTOMAKI P HEIM S BROGGER A VATN M ROGNUM TO BORRESEN AL
Citation: Ra. Lothe et al., DELETION OF IP LOCI AND MICROSATELLITE INSTABILITY IN COLORECTAL POLYPS, Genes, chromosomes & cancer, 14(3), 1995, pp. 182-188
TP53 MUTATIONS AND BREAST-CANCER PROGNOSIS - PARTICULARLY POOR SURVIVAL RATES FOR CASES WITH MUTATIONS IN THE ZINC-BINDING DOMAINS
Authors: BORRESEN AL ANDERSEN TI EYFJORD JE CORNELIS RS THORLACIUS S BORG A JOHANSSON U THEILLET C SCHERNECK S HARTMAN S CORNELISSE CJ HOVIG E DEVILEE P
Citation: Al. Borresen et al., TP53 MUTATIONS AND BREAST-CANCER PROGNOSIS - PARTICULARLY POOR SURVIVAL RATES FOR CASES WITH MUTATIONS IN THE ZINC-BINDING DOMAINS, Genes, chromosomes & cancer, 14(1), 1995, pp. 71-75
SOMATIC MUTATIONS IN THE HMSH2 GENE IN MICROSATELLITE UNSTABLE COLORECTAL CARCINOMAS
Authors: BORRESEN AL LOTHE RA MELING GI LYSTAD S MORRISON P LIPFORD J KANE MF ROGNUM TO KOLODNER RD
Citation: Al. Borresen et al., SOMATIC MUTATIONS IN THE HMSH2 GENE IN MICROSATELLITE UNSTABLE COLORECTAL CARCINOMAS, Human molecular genetics, 4(11), 1995, pp. 2065-2072
DETECTION OF THE POOR METABOLIZER-ASSOCIATED CYP2D6(D) GENE DELETION ALLELE BY LONG-PCR TECHNOLOGY
Authors: STEEN VM ANDREASSEN OA DALY AK TEFRE T BORRESEN AL IDLE JR GULBRANDSEN AK
Citation: Vm. Steen et al., DETECTION OF THE POOR METABOLIZER-ASSOCIATED CYP2D6(D) GENE DELETION ALLELE BY LONG-PCR TECHNOLOGY, Pharmacogenetics, 5(4), 1995, pp. 215-223
TP53 MUTATIONS AND ABNORMAL P53 PROTEIN STAINING IN BREAST CARCINOMASRELATED TO PROGNOSIS
Authors: THORLACIUS S THORGILSSON B BJORNSSON J TRYGGVADOTTIR L BORRESEN AL OGMUNDSDOTTIR HM EYFJORD JE
Citation: S. Thorlacius et al., TP53 MUTATIONS AND ABNORMAL P53 PROTEIN STAINING IN BREAST CARCINOMASRELATED TO PROGNOSIS, European journal of cancer, 31A(11), 1995, pp. 1856-1861
DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR
Authors: ANDERSEN TI PAUS E NESLAND JM MCKENZIE SJ BORRESEN AL
Citation: Ti. Andersen et al., DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR, Acta oncologica, 34(4), 1995, pp. 499-504
MOLECULAR-GENETIC CHANGES IN HUMAN MALE GERM-CELL TUMORS
Authors: LOTHE RA PELTOMAKI P TOMMERUP N FOSSA SD STENWIG AE BORRESEN AL NESLAND JM
Citation: Ra. Lothe et al., MOLECULAR-GENETIC CHANGES IN HUMAN MALE GERM-CELL TUMORS, Laboratory investigation, 73(5), 1995, pp. 606-614
TP53 MUTATIONS IN PROSTATIC-CANCER - ANALYSIS OF PRETREATMENT AND POSTTREATMENT ARCHIVAL FORMALIN-FIXED TUMOR-TISSUE
Authors: BERNER A GEITVIK G KARLSEN F FOSSA SD NESLAND JM BORRESEN AL
Citation: A. Berner et al., TP53 MUTATIONS IN PROSTATIC-CANCER - ANALYSIS OF PRETREATMENT AND POSTTREATMENT ARCHIVAL FORMALIN-FIXED TUMOR-TISSUE, Journal of pathology, 176(3), 1995, pp. 299-308
ALTERATIONS AT CHROMOSOME-17 LOCI IN PERIPHERAL-NERVE SHEATH TUMORS
Authors: LOTHE RA SLETTAN A SAETER G BROGGER A BORRESEN AL NESLAND JM
Citation: Ra. Lothe et al., ALTERATIONS AT CHROMOSOME-17 LOCI IN PERIPHERAL-NERVE SHEATH TUMORS, Journal of neuropathology and experimental neurology, 54(1), 1995, pp. 65-73
Risultati: 1-25 | 26-50 | 51-52